EE200300584A - Ravimikombinatsioon, mis sisaldab kas (S)-2-etoksü-3-[4-(2-{4-metaansulfonüüloksüfenüül}etoksü)fenüül]propaanhapet või 3-{4-[2-(4-tert-butoksükarbonüülaminofenüül)etoksü]fenüül}-(S)-2-etoksüpropaanhapet ja biguaniidravimit - Google Patents

Ravimikombinatsioon, mis sisaldab kas (S)-2-etoksü-3-[4-(2-{4-metaansulfonüüloksüfenüül}etoksü)fenüül]propaanhapet või 3-{4-[2-(4-tert-butoksükarbonüülaminofenüül)etoksü]fenüül}-(S)-2-etoksüpropaanhapet ja biguaniidravimit

Info

Publication number
EE200300584A
EE200300584A EEP200300584A EEP200300584A EE200300584A EE 200300584 A EE200300584 A EE 200300584A EE P200300584 A EEP200300584 A EE P200300584A EE P200300584 A EEP200300584 A EE P200300584A EE 200300584 A EE200300584 A EE 200300584A
Authority
EE
Estonia
Prior art keywords
ethoxy
phenyl
drug
methanesulfonyloxyphenyl
butoxycarbonylaminophenyl
Prior art date
Application number
EEP200300584A
Other languages
English (en)
Inventor
Hman Peter
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of EE200300584A publication Critical patent/EE200300584A/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
EEP200300584A 2001-06-01 2002-05-30 Ravimikombinatsioon, mis sisaldab kas (S)-2-etoksü-3-[4-(2-{4-metaansulfonüüloksüfenüül}etoksü)fenüül]propaanhapet või 3-{4-[2-(4-tert-butoksükarbonüülaminofenüül)etoksü]fenüül}-(S)-2-etoksüpropaanhapet ja biguaniidravimit EE200300584A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0101980A SE0101980D0 (sv) 2001-06-01 2001-06-01 Pharmaceutical combination
PCT/SE2002/001038 WO2002096402A1 (en) 2001-06-01 2002-05-30 A pharmaceutical combination comprising either (s)-2-ethoxy-3- [4-(2- {4-methane sulfonyl oxyphenyl} ethoxy) phenyl] propanoic acid or 3-{4-[2- (4-tert-butoxy carbonyl aminophenyl) ethoxy] phenyl} -(s)-2-ethoxy propanoic acid and a biguanide drug

Publications (1)

Publication Number Publication Date
EE200300584A true EE200300584A (et) 2004-02-16

Family

ID=20284362

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200300584A EE200300584A (et) 2001-06-01 2002-05-30 Ravimikombinatsioon, mis sisaldab kas (S)-2-etoksü-3-[4-(2-{4-metaansulfonüüloksüfenüül}etoksü)fenüül]propaanhapet või 3-{4-[2-(4-tert-butoksükarbonüülaminofenüül)etoksü]fenüül}-(S)-2-etoksüpropaanhapet ja biguaniidravimit

Country Status (25)

Country Link
US (1) US20040152771A1 (et)
EP (2) EP1666034A1 (et)
JP (1) JP2004532864A (et)
KR (1) KR20040008202A (et)
CN (1) CN1535144A (et)
AT (1) ATE336993T1 (et)
BR (1) BR0210128A (et)
CA (1) CA2448643A1 (et)
CO (1) CO5540375A2 (et)
CZ (1) CZ20033234A3 (et)
DE (1) DE60214185T2 (et)
EE (1) EE200300584A (et)
ES (1) ES2269686T3 (et)
HK (1) HK1062813A1 (et)
HU (1) HUP0400946A3 (et)
IL (1) IL159033A0 (et)
IS (1) IS7058A (et)
MX (1) MXPA03011005A (et)
NO (1) NO20035237D0 (et)
PL (1) PL367891A1 (et)
RU (1) RU2003136154A (et)
SE (1) SE0101980D0 (et)
SK (1) SK14702003A3 (et)
WO (1) WO2002096402A1 (et)
ZA (1) ZA200309264B (et)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201636015A (zh) * 2013-07-05 2016-10-16 卡地拉保健有限公司 協同性組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5783556A (en) * 1996-08-13 1998-07-21 Genentech, Inc. Formulated insulin-containing composition
US6552055B2 (en) * 1996-12-11 2003-04-22 Dana-Farber Cancer Institute Methods and pharmaceutical compositions for inhibiting tumor cell growth
US6011049A (en) * 1997-02-19 2000-01-04 Warner-Lambert Company Combinations for diabetes
SE9801990D0 (sv) * 1998-06-04 1998-06-04 Astra Ab New 3-aryl propionic acid derivatives and analogs
SE9801992D0 (sv) * 1998-06-04 1998-06-04 Astra Ab New 3-aryl-2-hydroxypropionic acid derivative I
ATE266409T1 (de) * 2000-04-13 2004-05-15 Pfizer Prod Inc Synergistische wirkung von glyburide und milrinone

Also Published As

Publication number Publication date
DE60214185D1 (en) 2006-10-05
BR0210128A (pt) 2004-06-08
HK1062813A1 (en) 2004-11-26
HUP0400946A3 (en) 2007-11-28
WO2002096402A1 (en) 2002-12-05
EP1666034A1 (en) 2006-06-07
CN1535144A (zh) 2004-10-06
EP1404309B1 (en) 2006-08-23
MXPA03011005A (es) 2004-02-27
SK14702003A3 (sk) 2004-09-08
ES2269686T3 (es) 2007-04-01
NO20035237D0 (no) 2003-11-25
SE0101980D0 (sv) 2001-06-01
EP1404309A1 (en) 2004-04-07
ZA200309264B (en) 2005-02-28
CZ20033234A3 (cs) 2004-12-15
ATE336993T1 (de) 2006-09-15
JP2004532864A (ja) 2004-10-28
US20040152771A1 (en) 2004-08-05
HUP0400946A2 (hu) 2004-08-30
PL367891A1 (en) 2005-03-07
KR20040008202A (ko) 2004-01-28
IS7058A (is) 2003-11-28
DE60214185T2 (de) 2007-07-19
CO5540375A2 (es) 2005-07-29
CA2448643A1 (en) 2002-12-05
IL159033A0 (en) 2004-05-12
RU2003136154A (ru) 2005-02-10

Similar Documents

Publication Publication Date Title
BR9910913A (pt) Composto, processo para a preparação de um composto, formulação farmacêutica, uso de um composto, e, processo para a profilaxia e/ou tratamento de condições clìnicas associadas com resistência a insulina
HRP20090229T1 (en) Combination comprising n-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl] phenyl)pyridine-3-sulphonamide and a biphosphonate
PT998473E (pt) Modificacao da forma de cristal de um derivado de n-fenil-2-pirimidinoamina processos para a sua preparacao e sua utilizacao
RU2006107653A (ru) Связующее вспомогательное вещество и приготовленная на его основе таблетка в форме капли
BR0207509A (pt) Pirazolilpirimidinas
NO20022591D0 (no) Finmalt form av (S)-2-etoksy-3-[4-(2-{4- metansulfonyloksyfenyl}etoksy)fenyl]propansyre
DK1599455T3 (da) 4-(3-(2-phenyl-oxazol-4-ylmethoxy)-cyclohexyloxy)-butansyrederivater og beslægtede forbindelser som PPAR modulatorer til behandling af type 2 diabetes og aterosclerose
IS8224A (is) Amínsölt (-)-2-{[2-(4-hýdroxýfenýl)etýl]-þíó}-3-[4-(2-{4-[(metýlsúlfónýl)oxý]fenoxý}etýl)fenýl]própansýru og notkun þeirra í læknisfræði
EE200300584A (et) Ravimikombinatsioon, mis sisaldab kas (S)-2-etoksü-3-[4-(2-{4-metaansulfonüüloksüfenüül}etoksü)fenüül]propaanhapet või 3-{4-[2-(4-tert-butoksükarbonüülaminofenüül)etoksü]fenüül}-(S)-2-etoksüpropaanhapet ja biguaniidravimit
BR0110399A (pt) Composição herbicida sólida
EE200300577A (et) Ravimikombinatsioon, mis sisaldab kas (S)-2-etoksü-3-[4-(2-{4-metaansulfonüüloksüfenüül}etoksü)fenüül]propaanhapet või 3-{4-[2-(4-tert-butoksükarbonüülaminofenüül)etoksü]fenüül}-(S)-2-etoksüpropaanhapet ja insuliini
EE200300583A (et) Ravimikombinatsioon, mis sisaldab kas (S)-2-etoksü-3-[4-(2-{4-metaansulfonüüloksüfenüül}etoksü)fenüül]propaanhapet või 3-{4-[2-(4-tert-butoksükarbonüülaminofenüül)etoksü]fenüül}-(S)-2-etoksüpropaanhapet ja sulfonüüluureat
ES2165410T3 (es) Nuevas 5-(ariloxi-metil)-oxazolinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
RS52014B (sr) Nova so benzoilgvanidina
TW200503679A (en) Therapeutic agents
DE60142063D1 (de) (2s)-2-(adamantan-1-ylmethoxycarbonylamino)-3-(4-(2-(1,4,5,6-tetrahydropyrimidin-2-ylcarbamoyl)ethyl)benzoylamino)propion säureisopropylester, dessen herstellung und dessen verwendung
ATE350038T1 (de) Pharmazeutische zubereitungen enthaltend nanopartikel von 2-(4-ethoxy-phenyl)-3-(4- methansulphonyl-phenyl)-pyrazolo 1,5-böpyridazi
AR045279A1 (es) Trans-1-(6-cloro-3-fenilindan-1-il)-3,3-dimetilpiperazina
FI980508A0 (fi) 2-(3,5-difluorfenyl)-3-(4-(metylsulfonyl)fenyl)-2-cyklopenten-1-on anvaendbar som COX-2 inhibitor